{"id":"https://openalex.org/W4297846523","doi":"https://doi.org/10.2147/dmso.s4283","title":"Role and development of GLP-1 receptor agonists in the management of diabetes","display_name":"Role and development of GLP-1 receptor agonists in the management of diabetes","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W4297846523","doi":"https://doi.org/10.2147/dmso.s4283","mag":"1988105132","pmid":"https://pubmed.ncbi.nlm.nih.gov/20148188","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2818016"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s4283","doi":"https://doi.org/10.2147/dmso.s4283","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s4283","pdf_url":null,"source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2147/dmso.s4283","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000777749","display_name":"Josephine Mary Egan","orcid":"https://orcid.org/0000-0002-8945-0053","observed_orcids":["https://orcid.org/0000-0002-8945-0053"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine Egan","raw_affiliation_strings":["National institute on Aging, intramural research Program, Baltimore, Maryland, USA","National institute on Aging, intramural research Program, Biomedical research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA","National institutes of Health,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National institute on Aging, intramural research Program, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I4210136897"]},{"raw_affiliation_string":"National institute on Aging, intramural research Program, Biomedical research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I4210136897"]},{"raw_affiliation_string":"National institutes of Health,","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058369658","display_name":"Chee W. Chia","orcid":"https://orcid.org/0000-0003-3218-0141","observed_orcids":["https://orcid.org/0000-0003-3218-0141"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210136897","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210136897"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chee W. Chia","raw_affiliation_strings":["National institute on Aging, intramural research Program, Baltimore, Maryland, USA","National institute on Aging, intramural research Program, Biomedical research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA","National institutes of Health,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National institute on Aging, intramural research Program, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I4210136897"]},{"raw_affiliation_string":"National institute on Aging, intramural research Program, Biomedical research Center, 251 Bayview Boulevard, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I4210136897"]},{"raw_affiliation_string":"National institutes of Health,","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.3839,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.80870329,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"Volume 2","issue":null,"first_page":"37","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9850000143051147},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9110000133514404},{"id":"https://openalex.org/keywords/incretin-hormones","display_name":"incretins","score":0.8519999980926514},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9020000100135803},{"id":"https://openalex.org/keywords/glucagon-suppression","display_name":"glucagon suppression","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.9639999866485596},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.8560000061988831},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6330000162124634},{"id":"https://openalex.org/keywords/enteroendocrine-l-cells","display_name":"enteroendocrine L cells","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7418584823608398},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7045564651489258},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6802041530609131},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6341081857681274},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.620298445224762},{"id":"https://openalex.org/C103395026","wikidata":"https://www.wikidata.org/wiki/Q5380231","display_name":"Enteroendocrine cell","level":4,"score":0.6048213839530945},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5965169072151184},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.571851372718811},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5194786787033081},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5187128186225891},{"id":"https://openalex.org/C75908981","wikidata":"https://www.wikidata.org/wiki/Q28578","display_name":"Appetite","level":2,"score":0.5124462246894836},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5022647380828857},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4915066659450531},{"id":"https://openalex.org/C2780768396","wikidata":"https://www.wikidata.org/wiki/Q66310097","display_name":"Proglucagon","level":5,"score":0.49092820286750793},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4804527461528778},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.42334023118019104},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.37802961468696594},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.21252000331878662},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.08100372552871704}],"mesh":[],"locations_count":8,"locations":[{"id":"doi:10.2147/dmso.s4283","doi":"https://doi.org/10.2147/dmso.s4283","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s4283","pdf_url":null,"source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"doi:10.2147/dmsott.s4283","doi":"https://doi.org/10.2147/dmsott.s4283","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmsott.s4283","pdf_url":"https://www.dovepress.com/getfile.php?fileID=4805","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1948845","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2818016","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:20148188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20148188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2818016","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2818016/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:557b3719c76d42cf8151d5df75f42c68","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/557b3719c76d42cf8151d5df75f42c68","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol 2009, Iss default, Pp 37-49 (2009)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/3139","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/role-and-development-of-glp-1-receptor-agonists-in-the-management-of-d-peer-reviewed-article-DMSO","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"mag:1988105132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20148188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.2147/dmso.s4283","doi":"https://doi.org/10.2147/dmso.s4283","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s4283","pdf_url":null,"source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2666787912","display_name":"Drug Development of GLP-1 receptor agonists","funder_award_id":"Z01AG000905","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4297846523.pdf","grobid_xml":"https://content.openalex.org/works/W4297846523.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W1852436006","https://openalex.org/W1967331905","https://openalex.org/W1969932276","https://openalex.org/W1977881896","https://openalex.org/W1978279496","https://openalex.org/W1978953702","https://openalex.org/W1980288013","https://openalex.org/W1981183973","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1986331352","https://openalex.org/W1987182389","https://openalex.org/W2011820280","https://openalex.org/W2013842626","https://openalex.org/W2013851956","https://openalex.org/W2016193795","https://openalex.org/W2017201029","https://openalex.org/W2017518223","https://openalex.org/W2018192866","https://openalex.org/W2027433835","https://openalex.org/W2027593203","https://openalex.org/W2028272916","https://openalex.org/W2033072177","https://openalex.org/W2035284219","https://openalex.org/W2037839438","https://openalex.org/W2039296612","https://openalex.org/W2041150765","https://openalex.org/W2048372084","https://openalex.org/W2050826565","https://openalex.org/W2059117845","https://openalex.org/W2068488844","https://openalex.org/W2070710390","https://openalex.org/W2071835038","https://openalex.org/W2074956966","https://openalex.org/W2078115857","https://openalex.org/W2084534846","https://openalex.org/W2087707716","https://openalex.org/W2089304685","https://openalex.org/W2095959590","https://openalex.org/W2096716906","https://openalex.org/W2098459806","https://openalex.org/W2101005046","https://openalex.org/W2102400698","https://openalex.org/W2103516789","https://openalex.org/W2106824929","https://openalex.org/W2118100404","https://openalex.org/W2129377335","https://openalex.org/W2129449971","https://openalex.org/W2132613598","https://openalex.org/W2134636215","https://openalex.org/W2135854640","https://openalex.org/W2138077952","https://openalex.org/W2140978079","https://openalex.org/W2142903571","https://openalex.org/W2143014102","https://openalex.org/W2146466098","https://openalex.org/W2147817624","https://openalex.org/W2148798434","https://openalex.org/W2162934281","https://openalex.org/W2164416879","https://openalex.org/W2164961795","https://openalex.org/W2169558934","https://openalex.org/W2172204314","https://openalex.org/W2313838658","https://openalex.org/W2320948677","https://openalex.org/W2330054654","https://openalex.org/W2333502658","https://openalex.org/W2335557701","https://openalex.org/W2344620176","https://openalex.org/W4232199564","https://openalex.org/W6670416225","https://openalex.org/W7075701132"],"related_works":["https://openalex.org/W2266855174","https://openalex.org/W2066406526","https://openalex.org/W2038099154","https://openalex.org/W2082763759","https://openalex.org/W4394759794","https://openalex.org/W4200525428","https://openalex.org/W2001188295","https://openalex.org/W2094604239","https://openalex.org/W1997947019","https://openalex.org/W2080509524"],"abstract_inverted_index":{"Role":[0],"and":[1,101,112,117,130,148,171,188],"development":[2,190],"of":[3,10,19,42,81,90,109,124,166,183,186,191,196],"GLP-1":[4,50,141,158,167,187],"receptor":[5,159],"agonists":[6],"in":[7,45,56,72,87,98,105,121,169],"the":[8,43,88,122,163,184,189],"management":[9],"diabetes":[11,202],"Chee":[12],"W":[13],"Chia,":[14],"Josephine":[15],"M":[16],"EganNational":[17],"Institutes":[18],"Health,":[20],"National":[21],"Institute":[22],"on":[23],"Aging,":[24],"Intramural":[25],"Research":[26],"Program,":[27],"Baltimore,":[28],"Maryland,":[29],"USAAbstract:":[30],"Glucagon-like":[31],"peptide-1":[32],"(GLP-1)":[33],"is":[34,142,168],"a":[35,79,96,181],"hormone":[36],"secreted":[37],"from":[38,75,84],"enteroendocrine":[39],"L":[40],"cells":[41,86],"intestine":[44],"response":[46],"to":[47,137,144],"food.":[48],"Exogenous":[49],"administration":[51],"at":[52,179],"pharmacological":[53],"doses":[54],"results":[55],"many":[57],"effects":[58,165],"that":[59,161],"are":[60,173],"beneficial":[61],"for":[62,152,194],"treating":[63],"type":[64],"2":[65],"diabetes,":[66],"these":[67],"include:":[68],"(1)":[69],"an":[70,119],"increase":[71,120],"insulin":[73],"secretion":[74,83],"\u03b2":[76],"cells;":[77],"(2)":[78],"suppression":[80],"glucagon":[82],"\u03b1":[85],"presence":[89],"hyperglycemia":[91],"but":[92],"not":[93,150],"hypoglycemia;":[94],"(3)":[95],"delay":[97],"gastric":[99],"emptying":[100],"gut":[102],"motility":[103],"which":[104,134],"turns":[106],"delays":[107],"absorption":[108],"ingested":[110],"nutrients":[111],"dampens":[113],"post-prandial":[114],"glucose":[115],"excursion;":[116],"(4)":[118],"duration":[123],"postprandial":[125],"satiety":[126],"therefore":[127],"suppressing":[128],"appetite":[129],"decreasing":[131],"food":[132],"intake":[133],"eventually":[135],"leads":[136],"weight":[138],"loss.":[139],"However,":[140],"subject":[143],"rapid":[145],"enzymatic":[146],"degradation,":[147],"therefore,":[149],"suitable":[151],"long-term":[153],"treatment.":[154],"A":[155],"synthetic":[156],"enzyme-resistant":[157],"agonist":[160],"reproduces":[162],"biological":[164],"use":[170],"more":[172],"under":[174],"development.":[175],"This":[176],"review":[177],"aims":[178],"providing":[180],"summary":[182],"properties":[185],"GLP-1-based":[192],"therapies":[193],"treatment":[195],"diabetes.Keywords:":[197],"incretin,":[198],"GLP-1,":[199],"GLP-1R":[200],"agonist,":[201]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-10-01T00:00:00"}